CRSP

CRISPR THERAPEUTICS AG

Healthcare | Mid Cap

-$1.44

EPS Forecast

$6.63

Revenue Forecast

Announcing earnings for the quarter ending 2025-06-30 soon
HALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncREPLReplimune Group IncNVAXNovavax IncTECHBio-techne CorpMRNAModerna IncDNLIDenali Therapeutics IncNBIXNeurocrine Biosciences IncRGENRepligen Corp